ArticleMikrochimica acta2026
Fe/Co-MOF-based cascade biocatalytic platform for ultrasensitive detection of α-amylase.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel biosensor for detection of α-amylase, a key functional enzyme in Daqu fermentation, has been developed addressing the challenges of interference and inefficiency associated with conventional methods. In the multi-enzymes cascade system (Glu-GOx@MOF), the enzymes were immobilized on metal–organic frameworks (MOF) with excellent peroxidase-like activity through a covalent bonding method, enabling efficient and sensitive detection of α-amylase activity. Combining theoretical calculations with experiments, we have demonstrated that the Fe/Co-MOF possesses remarkable peroxidase-mimicking properties. Therefore, Fe/Co-MOF not only serves as a reliable carrier for multiple enzymes but also functions as a high-performance nanozyme in cascade reactions. Compared with natural enzymes, this biocatalytic platform exhibits excellent cascade catalytic activity and stability in various harsh environments. On this basis, a cascade biocatalytic platform for α-amylase detection was developed, demonstrating a wide linear range from 25 to 18,000 U L⁻1 and a low detection limit of 10.8 U L⁻1. This work not only provides a robust tool for α-amylase monitoring in food quality control but also establishes a novel cascade amplification strategy utilizing enzyme-MOF hybrid systems for biosensing applications.
Indexed as
Identifiers
41925879What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.